News

The ACT EU workplan for 2025-2026 outlines the initiative's areas of focus, which reflect feedback from stakeholders.

The revised ICH guideline on good clinical practice (principles and Annex 1) have been published.

The enhanced portal aims to benefit the public by making it easier to search for publicly available information on clinical trials in the EU and EEA.

ACT EU has published two new webpages with information of interest to the network and clinical trial stakeholders.

Revised rules for Clinical Trials Information System (CTIS) become applicable.

Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.

The revised transparency rules for the Clinical Trials Information System (CTIS) will become applicable on 18 June 2024, with the launch of a new version of the CTIS public portal.

The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU).

All ongoing clinical trials in the EU must be transitioned to the Clinical Trials Information System (CTIS) by 31 January 2025.